Predictors of radiographic joint damage in patients with early rheumatoid arthritis.
about
Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Genetic risk score predicting risk of rheumatoid arthritis phenotypes and age of symptom onsetCost-effectiveness of adding magnetic resonance imaging to rheumatoid arthritis management.Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment.Relationship between time-integrated disease activity estimated by DAS28-CRP and radiographic progression of anatomical damage in patients with early rheumatoid arthritis.Time-averaged disease activity fits better joint destruction in rheumatoid arthritis.Leflunomide in the treatment of patients with early rheumatoid arthritis--results of a prospective non-interventional studyProfile and course of early rheumatoid arthritis in Morocco: a two-year follow-up study.Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD studyThe effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy.Conventional radiography requires a MRI-estimated bone volume loss of 20% to 30% to allow certain detection of bone erosions in rheumatoid arthritis metacarpophalangeal joints.Role of C-reactive protein in osteoclastogenesis in rheumatoid arthritis.We should not forget the foot: relations between signs and symptoms, damage, and function in rheumatoid arthritisLack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial.EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).MRI identifies plantar plate pathology in the forefoot of patients with rheumatoid arthritis.Ex vivo interleukin 1 receptor antagonist production on lipopolysaccharide stimulation is associated with rheumatoid arthritis and with joint damage.Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis.Pharmacological management of transient synovitis.Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study.Rheumatoid arthritis--early diagnosis and disease managementA systematic review of infliximab in the treatment of early rheumatoid arthritis.Efficacy and Safety of Rituximab in Biologic-Naive Patients with Rheumatoid Arthritis vs Anti-Tnf Therapy Failure.Certolizumab in the long-term treatment of rheumatoid arthritis.Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year.The epidemiology of early inflammatory arthritis.What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review.S100A8/A9 as a biomarker for synovial inflammation and joint damage in patients with rheumatoid arthritis.Judicious use of biologicals in juvenile idiopathic arthritis.Relationship between disease activity indices and their individual components and radiographic progression in RA: a systematic literature review.Predictors of remission, erosive disease and radiographic progression in a Colombian cohort of early onset rheumatoid arthritis: a 3-year follow-up study.Clinical efficacy, radiographic progression, and safety through 156 weeks of therapy with subcutaneous golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis despite prior methotrexate therapy: final resultsPredicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study.Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis.Intra-individual assessment of inflammatory severity and cartilage composition of finger joints in rheumatoid arthritis.Classifying radiographic progression status in early rheumatoid arthritis patients using propensity scores to adjust for baseline differences.Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis.Disease activity trajectories in early rheumatoid arthritis following intensive DMARD therapy over 3 years: association with persistence to therapy.Human leukocyte antigen-G polymorphism influences the age of onset and autoantibody status in rheumatoid arthritis.
P2860
Q27687777-0D9311DB-51BF-4DE6-B138-E25BDFE4ADCAQ31031177-06E267CC-55F6-4A78-93B8-BAC3447E3F5CQ33717053-1059A24C-E83E-4577-9139-7C326EAFE283Q33896725-DF48F2BB-1619-4864-8A93-EC02BFD59DE6Q33915665-C2F03456-A7FC-4207-9556-4F8211810575Q33918379-21AC3C3A-1677-4EBD-A0BB-1F83D4180AC7Q33956623-02D75564-785A-4797-A44C-DA7AF46F4C5AQ34082035-BB79F223-B2A2-423C-95C9-E5471BEF9C4FQ34613963-89FF2E42-F61F-46CA-AA4D-5F73F681A88CQ34626882-C51A5953-BC19-49E6-8D5E-82B94E124BBCQ34897214-AF3097F5-396F-46E3-BED6-5A8BCD9BA407Q35213253-22547D0F-9262-42CF-8405-440793BDCB79Q35463979-AF078473-E3FB-43F5-A313-21046E006832Q35554275-FEA6F2B8-8E9F-4932-BB29-DA4E3B43F18EQ35638360-20D4DDEE-A869-41DC-B1AF-3A64A86990DAQ35859141-6557A775-0E2F-4F4E-B64A-F624822F262EQ35953473-5160FFFF-0BE3-4040-90AD-8FF626A7B2B4Q35953503-DED54B2F-7750-4AE7-ADC2-51E353B213F1Q36349593-8596EDA9-C769-47A8-A358-F9DA60D9E9FBQ36993230-82D59B0D-FB79-4CD8-A84F-EB93C3F4BB65Q37043713-0B02E5A7-89F6-4DE0-BC13-B084E1CBFEA3Q37160391-D7B97164-03B9-4787-975D-D6BCA77F7497Q37267285-AB0BA8F5-37C4-475E-B434-2B028639BE40Q37358254-F7E871E4-AE54-442D-9745-523F5F01DB17Q37690878-EF72D88F-9A8B-408D-8DF3-EFE2217D3BC9Q37889117-7F87C164-44D4-46CE-BA08-CF5A2DDD8C32Q38097740-C7C0327B-506F-44FB-A366-1A87CE5915A8Q38191587-AB93782C-D49E-4873-8328-8557A57498C0Q38248905-70E5C67F-B211-482E-8530-1E52C14DCBCBQ38270519-FD8EB7FB-BA7C-435B-9F2F-24EB35F20402Q39866800-352831AF-82FA-4125-AF7E-AB849794F59DQ40948951-D64D2FA5-06EE-4FF3-8480-F49F82C22566Q42654393-641EAE8C-D608-4A84-AAED-49FA75E232A3Q44898212-98036803-3163-490E-A4F5-FDB26458D202Q45772376-D6B02E0B-8DD3-4616-B28B-ABFE2112B573Q45959202-4AE8F24E-99D7-45B8-B1DA-A16E29722316Q46116182-81018732-F777-4C9F-BEE2-F101905D7461Q47692825-457CF50A-7025-4DAF-8342-6E3506CF3824Q48282881-7959122F-65D7-4F15-9AB5-2DDEF75ACBD6Q51058843-ADB218A6-C244-4E67-9C4D-5BC586B3A33B
P2860
Predictors of radiographic joint damage in patients with early rheumatoid arthritis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Predictors of radiographic joint damage in patients with early rheumatoid arthritis.
@ast
Predictors of radiographic joint damage in patients with early rheumatoid arthritis.
@en
type
label
Predictors of radiographic joint damage in patients with early rheumatoid arthritis.
@ast
Predictors of radiographic joint damage in patients with early rheumatoid arthritis.
@en
prefLabel
Predictors of radiographic joint damage in patients with early rheumatoid arthritis.
@ast
Predictors of radiographic joint damage in patients with early rheumatoid arthritis.
@en
P2093
P2860
P356
P1476
Predictors of radiographic joint damage in patients with early rheumatoid arthritis.
@en
P2093
Bezemer PD
Dijkmans BA
van Schaardenburg D
van der Horst-Bruinsma IE
P2860
P304
P356
10.1136/ARD.60.10.924
P407
P577
2001-10-01T00:00:00Z